Why the study?
Due to the undetermined course and regional variability of the COVID-19 pandemic, uncertainty existed regarding how and when to resume and deliver cardiac electrophysiology services for patients with arrhythmia.
This joint society document provides essential guidance for safely resuming electrophysiology procedures and outpatient care during the COVID-19 pandemic.
Answers are grounded in this paper and cite their sources.
Supports immediate adoption of risk-stratified EP prioritization and safety pathways; extends prior pandemic guidance with multi-society consensus.
Coronavirus disease 2019 (COVID-19) has presented substantial challenges to patient care and impacted healthcare delivery, including cardiac electrophysiology practice throughout the globe. Based upon the undetermined course and regional variability of the pandemic, there is uncertainty as to how and when to resume and deliver electrophysiology services for patients with arrhythmia. This joint document from representatives of the Heart Rhythm Society, American Heart Association, and American College of Cardiology seeks to provide guidance for clinicians and institutions reestablishing safe electrophysiological care. To achieve this aim, we address regional and local COVID-19 disease status, the role of viral screening and serological testing, return-to-work considerations for exposed or infected health care workers, risk stratification and management strategies based on COVID-19 disease burden, institutional preparedness for resumption of elective procedures, patient preparation and communication, prioritization of procedures, and development of outpatient and periprocedural care pathways.
No takes yet. Share an insight, caveat, or question.
Lakkireddy et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: